跳至主要内容
临床试验/IRCT20110628006907N15
IRCT20110628006907N15尚未招募未知

Evaluation of the effectiveness of intrathecal injection of allogeneic umbilical cord derived mesenchymal stem cells in the phenotypic changes of Spinal Muscular Atrophy type I, II and III in comparison with control group, A Clinical trial phase I, II

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 months 至 16 years(—)
性别
All

入选标准

  • Genetically confirmed deletion of SMN1 gene for the diagnosis of SMA disease, SMN2 gene copy number count for the diagnostic classification of disease type, Minimum age of 6 months in type I, Ventilator independent patients at the beginning of treatment in type I, Maximum age of 16 years in type II and III, Ventilator independent patients in type II and III, Absence of brain damage, Absence of liver disease, Absence of renal disease, Absence of hematological disease, Informed consent of patients and their parents

排除标准

  • Acquired brain damage including hypoxia, ?Structural and functional brain disorders, Acute infections such as( HCV, HIV,HBV), Malignancies, Hemorrhagic diathesis, Severe anemia ( Hb less than 8 gram/dl), Renal dysfunction, Hepatic dysfunction

研究者

相似试验